All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
CULLINAN THERAPEUTICS, INC. Last Reported: 5/31/2024 Stock Symbol: CGEM

Business Address

ONE MAIN STREET
SUITE 1350
CAMBRIDGE , MA US 02142

Mailing Address

ONE MAIN STREET
SUITE 1350
CAMBRIDGE , MA US 02142
Phone Number: 617-410-4650 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 6/30/2023 3/31/2023 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Cash and Cash Equivalents $74,228,000.00 $98,434,000.00 $141,834,000.00 $122,128,000.00 $242,657,000.00 $353,563,000.00 $76,118,000.00 $59,774,000.00 $88,105,000.00 $123,670,000.00 $293,537,000.00 $168,198,000.00 -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- $619,000.00 $619,000.00 -- $619,000.00 $619,000.00 -- -- -- -- -- -- -- -- -- --
Total Current Assets $445,721,000.00 $480,191,000.00 $498,235,000.00 $399,031,000.00 $582,075,000.00 $622,841,000.00 $322,312,000.00 $296,564,000.00 $328,838,000.00 $344,467,000.00 $447,293,000.00 $212,278,000.00 -- -- -- --
Property Plant and Equipement $913,000.00 $989,000.00 $1,158,000.00 $1,239,000.00 $792,000.00 $52,000.00 $64,000.00 $77,000.00 $89,000.00 $102,000.00 $115,000.00 $130,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $460,000.00 $459,000.00 $459,000.00 $459,000.00 $460,000.00 $100,000.00 $147,000.00 $147,000.00 $147,000.00 $147,000.00 $147,000.00 $2,300,000.00 -- -- -- --
Total Assets $449,430,000.00 $484,182,000.00 $521,984,000.00 $514,990,000.00 $617,237,000.00 $667,249,000.00 $437,463,000.00 $437,185,000.00 $453,404,000.00 $464,353,000.00 $479,666,000.00 $214,708,000.00 -- -- -- --
Accounts Payable $3,707,000.00 $2,493,000.00 $2,493,000.00 $2,031,000.00 $1,516,000.00 $3,099,000.00 $6,306,000.00 $3,169,000.00 $2,024,000.00 $1,510,000.00 $3,879,000.00 $9,679,000.00 -- -- -- --
Accrued Liabilities $16,889,000.00 $24,204,000.00 $15,531,000.00 $18,379,000.00 $13,507,000.00 $11,901,000.00 $10,432,000.00 $8,577,000.00 $5,839,000.00 $4,233,000.00 $6,015,000.00 $4,641,000.00 -- -- -- --
Total Current Liabilities $23,765,000.00 $30,287,000.00 $22,410,000.00 $29,341,000.00 $31,109,000.00 $62,631,000.00 $17,993,000.00 $11,811,000.00 $7,930,000.00 $5,813,000.00 $9,967,000.00 $14,394,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $663,997,000.00 $654,685,000.00 $639,066,000.00 $592,544,000.00 $610,965,000.00 $604,275,000.00 $592,839,000.00 $584,714,000.00 $569,835,000.00 $564,705,000.00 $560,366,000.00 $292,348,000.00 $152,580,000.00 $152,580,000.00 -- $138,543,000.00
Accumulated Other Comprehensive Loss $-331,000.00 $-129,000.00 $-1,625,000.00 $-1,242,000.00 $-3,929,000.00 $-3,633,000.00 $-3,134,000.00 $-838,000.00 $-58,000.00 $-115,000.00 $-60,000.00 $-2,000.00 $59,000.00 $203,000.00 -- $-4,000.00
Accumulated Deficit $-238,005,000.00 $-200,857,000.00 $-137,871,000.00 $-105,657,000.00 $-20,913,000.00 $3,891,000.00 $-171,007,000.00 $-158,909,000.00 $-126,400,000.00 $-109,000,000.00 $-93,409,000.00 $-93,339,000.00 $-64,993,000.00 $-55,135,000.00 -- $-41,540,000.00
Total Stockholders' Equity $425,665,000.00 $453,703,000.00 $499,574,000.00 $485,649,000.00 $586,128,000.00 $604,538,000.00 $418,702,000.00 $424,971,000.00 $443,386,000.00 $455,549,000.00 $466,901,000.00 $199,010,000.00 $87,648,000.00 $97,650,000.00 -- $97,001,000.00
Controlling Interest in Subsidiaries -- $192,000.00 -- -- -- $80,000.00 $768,000.00 $403,000.00 $2,088,000.00 $2,991,000.00 $2,798,000.00 $1,304,000.00 $1,863,000.00 $1,269,000.00 -- $864,000.00
Total Liabilities and Equity $449,430,000.00 $484,182,000.00 $521,984,000.00 $514,990,000.00 $617,237,000.00 $667,249,000.00 $437,463,000.00 $437,185,000.00 $453,404,000.00 $464,353,000.00 $479,666,000.00 $214,708,000.00 -- -- -- --

Statement of Operations

Date 3/31/2024 12/31/2023 6/30/2023 3/31/2023 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $30,646,000.00 $148,156,000.00 $79,487,000.00 $52,096,000.00 $19,680,000.00 $26,411,000.00 $24,536,000.00 $57,751,000.00 $36,873,000.00 $24,193,000.00 $12,415,000.00 -- $26,582,000.00 $16,669,000.00 $4,173,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $42,989,000.00 $190,649,000.00 $100,361,000.00 $62,756,000.00 $99,529,000.00 $69,763,000.00 $32,657,000.00 $86,897,000.00 $18,375,000.00 $34,175,000.00 $17,571,000.00 -- $11,499,000.00 $19,663,000.00 $5,541,000.00 --
Loss from Operations $-42,989,000.00 $-191,089,000.00 $-100,361,000.00 $-62,756,000.00 $-29,766,000.00 $207,022,000.00 $-32,657,000.00 $-67,954,000.00 $-33,607,000.00 $-15,232,000.00 $1,372,000.00 -- $-31,162,000.00 $-19,663,000.00 $-5,541,000.00 --
Loss Before Income Taxes -- $-169,223,000.00 $-90,355,000.00 $-58,141,000.00 $180,262,000.00 $240,135,000.00 $-32,460,000.00 -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.86 $-3.69 $-2.24 $-1.42 $-0.54 $3.65 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 43,011,000 41,550,000 39,952,000 40,682,000 44,966,000 44,873,000 -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.86 $-3.69 $-0.82 $-1.42 $-0.54 $3.77 -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 43,011,000 41,550,000 39,952,000 40,682,000 46,580,000 46,389,000 -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 34,900,878 -- -- -- --
Common Stock Shares Outstanding 43,065,645 42,900,083 42,735,304 39,343,601 45,743,027 45,396,398 44,660,026 44,292,102 43,660,909 43,526,224 43,516,125 29,381,125 -- -- -- --
Common Stock Value $4,000.00 $4,000.00 $4,000.00 $4,000.00 $5,000.00 $5,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 $3,000.00 $2,000.00 $2,000.00 -- $2,000.00
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding 647,500 647,500 647,500 -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 -- -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- $12.98 $12.98 -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com